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Abstract
Active muscles generate substantial mechanical forces by the contraction/relaxation cycle, and, to maintain an ordered
state, they require molecular structures of extraordinary stability. These forces are sensed and buffered by unusually long
and elastic filament proteins with highly repetitive domain arrays. Members of the myomesin protein family function as
molecular bridges that connect major filament systems in the central M-band of muscle sarcomeres, which is a central locus
of passive stress sensing. To unravel the mechanism of molecular elasticity in such filament-connecting proteins, we have
determined the overall architecture of the complete C-terminal immunoglobulin domain array of myomesin by X-ray
crystallography, electron microscopy, solution X-ray scattering, and atomic force microscopy. Our data reveal a dimeric tail-
to-tail filament structure of about 360 A ˚ in length, which is folded into an irregular superhelical coil arrangement of almost
identical a-helix/domain modules. The myomesin filament can be stretched to about 2.5-fold its original length by
reversible unfolding of these linkers, a mechanism that to our knowledge has not been observed previously. Our data
explain how myomesin could act as a highly elastic ribbon to maintain the overall structural organization of the sarcomeric
M-band. In general terms, our data demonstrate how repetitive domain modules such as those found in myomesin could
generate highly elastic protein structures in highly organized cell systems such as muscle sarcomeres.
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Introduction
Striated myofibrils are found in skeletal and cardiac muscle cells
and represent a highly organized cellular system for studying how
active force can be generated while the overall structural
organization of the underlying sarcomeric units is maintained. The
principal protein components of myofibrils are large longitudinal
filaments that include actin (thin filament), myosin (thick filament),
titin, and nebulin [1]. These filaments form a well-established
striated pattern of distinct zones, with the M-band at the center [2].
On activation, both substantial axial and radial forces are generated
within the overall sarcomere structure [3]. To maintain a constant
sarcomere volume under defined physiological conditions, these
forces can lead to changes in both radial and longitudinal contour
dimensions of the sarcomere. Under typical tension conditions, M-
band-associated thick filaments can substantially move away from
the sarcomeric center by 0.1 mm or more, which can lead to M-
band-induced instability of the sarcomere [4]. Because of the
presenceofastiffZ-diskarchitectureatthesarcomericperiphery,the
amount of movement decreases with the overall sarcomere length so
that the resting tension stays constant. In cardiac muscles, elastic M-
band motions are thought to correlate with heart beat rate [5],
rendering investigations of the underlying molecular parameters
highly relevant to heart and skeletal muscle research.
To ensure the restoration of sarcomere integrity on activation,
there are two principal structural compartments with elastic
properties. The first section is defined by the I-band segment,
which is situated between the stiff and highly interconnected Z-disk
at the sarcomere periphery and the more dynamic central A-band
and M-band [1,6–9]. The second site for molecular elasticity is
within the M-band, in which so-called M-bridges transversely
connect thick filaments with each other and with titin filaments
[2,10,11]. At the molecular level, M-bridges are thought to be
primarily composed of myomesin (MYOM1), which is universally
expressed, and two related isoforms, MYOM2 and MYOM3, which
show tissue-specific expression [12]. The three proteins share
a common domain topology that is characterized by a unique
N-terminal myosin-binding domain, followed by an array of
fibronectin type III (Fn-III) domains and immunoglobulin-like (Ig)
domains. In addition, they are capable of forming C-terminal tail-
PLoS Biology | www.plosbiology.org 1 February 2012 | Volume 10 | Issue 2 | e1001261to-tail homodimers, as shown for MYOM1 and MYOM3 [12,13].
Correct M-band localization of myomesin depends on the presence
of the C-terminal M-band region of the titin filament [14];
myomesin, titin, and the filament protein obscurin localize to the
same region [14], assigning myomesin a central role in maintaining
the M-band architecture. The crucial importance of myomesin for
sarcomereintegrityhas been shownbystudiessuppressingMYOM1,
leading to disintegration of obscurin in the M-band [15]. However,
in the absence of ultrastructural data at a molecular resolution, the
overall organization of M-bridges, and any associated requirements
for molecular elasticity, has remained largely unknown to date.
To address these questions we have made use of a previous
prediction suggesting that the entire C-terminal part of the
myomesin filament consists of an array of repetitive Ig domains
followed by exposed a-helical linkers [16]. Here, we report the
complete structure and extent of longitudinal elasticity of the
entire C-terminal tail-to-tail myomesin filament My9–My10–
My11–My12–(My13)2–My129–My119–My109–My99 (My9–My13).
It folds into a superhelical architecture with almost identical Ig
domain/helix modules and an estimated overall length of 360 A ˚ in
the absence of external tension. When stretched by low molecular
forces ,30 pN, myomesin can be extended reversibly by about 2.5-
folditsoriginal length,demonstratingthat thisfilament canadapt its
overall length to the changes in dynamic M-band dimensions that
have been observed in operating myofibrils [2,3].
Results
High-Resolution Structural Analysis of the C-Terminal
Myomesin Array My9–My13 by X-Ray Crystallography
First, we determined the overall architecture of the complete
myomesin domain array, including Ig domains My9–My10–
My11–My12–My13, from crystal structures of a total of three
filament fragments: the My9–My11 triplet, determined at 2.5 A ˚
resolution; the My10–My11 doublet, at 1.9 A ˚ resolution; and the
homodimeric My11–My13 triplet at 3.5 A ˚ resolution (Figures 1
and S1; Table 1). For further structural analysis and comparison,
we also used the published crystal structure of the My12–My13
fragment [16]. Although the structure-based sequence similarity of
the five Ig domains is generally below 25%, all Ig domains except
My13 belong to different sub-classes of the C-set type Ig domain
topology (Figures 2A and S2). A detailed comparison of the
individual Ig domains My9, My10, My11, My12, and My13 is
provided in Text S1.
As the available independent structures of helix-connected Ig
domain doublets show only limited variation in terms of domain/
domain arrangements (Figure 3), a reliable overall structural
model of the complete C-terminal myomesin Ig domain array
My9–My13 can be generated (Figure 1). This reveals a tail-to-tail
filament structure with an overall length of 360 A ˚ and a
pronounced zigzag-type arrangement within the central, C-
terminal myomesin dimerization module (My13)2, followed by a
superhelical coil arrangement towards the two symmetrical distal
ends. The right-handed superhelix is defined by almost constant
twist angles of neighboring My domains of 26–27u, except the
arrangement of My12–My13, which has an average twist angle of
68u and thus appears to be less regular than preceding parts My9–
My10–My11–My12 of the filament (Figures 1, 3, and S3C).
Remarkably, all five Ig domains of the myomesin filament are
connected by a-helices that areidentical in terms of orientationwith
respect to the preceding Ig domain, and they form a substantial,
structurallyhighlyconserved Igdomain/helixinterfacewithanarea
of 350–600 A ˚ 2 (Figure 2B). These interfaces involve loops that form
the C-terminal tip region in each Ig domain, and residues from the
first three helical turns form various specific interactions that shield
the N-terminal part of each a-helix from being completely exposed.
This conserved Ig domain/helix module, found in all four
myomesin My domains that are followed by a-helices (My9,
My10, My11, and My12), defines a new type of Ig domain topology
(Figures 2B and S3). We refer hereafter to this as the ‘‘IgH’’
segment, which to our knowledge has not been found in any other
muscle filament protein with repetitive Ig or Fn-III domains.
By contrast, we have observed neither a common interface nor a
similar orientation for any of the My–My domain-connecting
helices and subsequent Ig domains My10, My11, My12, and
My13 (Figures 1 and S3B). As the overall geometry of the IgH
segments is rigid, the limited variability in terms of arrangements
of neighboring My domains originates from the diverse helix/My
domain connections. Whereas long six-turn helices are found in
the My10–My11 and My12–My13 connecting segments, the
corresponding helices in the other two connecting segments, My9–
My10 and My11–My12, are slightly shorter, with about four turns
each (Figures 1 and 3). Because of the smaller length of their
linkers, My9–My10 and My11–My12 show limited direct
interactions in their respective Ig doublets, whereas in the other
two doublets, My10–My11 and My12–My13, the neighboring My
domains are too far away from each other to form an interface.
The complete filament structure of the My9–My13 dimer
therefore is defined by an arrangement of nine rigid bodies,
comprising eight Ig domains and the central My13 dimer. A
systematic distance analysis of the respective centers of gravity
reveals rather narrow average distance windows, specifically for
next neighbors (n, n+1, 50 A ˚) as well as for third and fourth next
neighbors (n, n+3, 116 A ˚; n, n+4, 153 A ˚), regardless of whether
they are intramolecular (within one My9–My13 monomer) or
intermolecular (generated from Ig domains across the My9–My13
dimer) (Figure 4A and 4B). This distinct distribution demonstrates
Author Summary
The contraction and relaxation cycles of active muscles
generate substantial mechanical forces, both axially and
radially, that place extraordinary stress on the molecular
structures within the muscle fibers. These forces are
sensed and buffered by unusually long and elastic filament
proteins with highly repetitive domain structures. Myome-
sin is one such repetitive filament protein that is thought
to form bridges between the main contractile filaments of
the muscle, providing the muscle structure with resistance
in the radial dimension. To investigate how the repetitive
structure of myomesin contributes to muscle elasticity, we
determined the overall architecture of its complete
repetitive domain array using a combination of four
complementary structural biology methods. Our study
reveals a long, dimeric tail-to-tail filament structure folded
into an irregular superhelical coil arrangement of almost
identical domain modules separated by short linkers.
When we applied tension to these myomesin filaments,
we found they could stretch to about 2.5 times their
original length by unfolding these linkers, and then return
to their original state when the tension was removed. Our
findings explain how myomesin might adapt its overall
length in response to the changing dimensions of the
contracting and relaxing muscle, so acting as a highly
elastic ribbon that maintains the overall structural
organization of the muscle fibers. More generally, these
findings demonstrate how repetitive domain modules,
such as those in myomesin, can provide elasticity to highly
organized biological structures.
Architecture and Extendibility of Myomesin
PLoS Biology | www.plosbiology.org 2 February 2012 | Volume 10 | Issue 2 | e1001261the highly regular arrangement of domains within the complete
My9–My13 filament dimer.
C-terminal Myomesin Filament Ultrastructure by Electron
Microscopy
To independently validate the crystallographic model of the
dimeric C-terminal myomesin filament, we used negative stain
transmission electron microscopy (EM) (Figures 5A and S4). As it was
difficult to define the precise filament ends when using a native My9–
My13 myomesin fragment—probably because of limited distal
flexibility coupled with the small size of each Ig domain—we fused
the N-termini of each of the two myomesin My9–My13 filament
protomers with maltose binding protein (MBP), which has about four
times the molecular mass of a single Ig domain. This engineered
version of the C-terminal myomesin filament revealed elongated
molecular images about 500 A ˚ long and 50 A ˚ wide (Figure S4). The
ends of the molecular images feature large globular densities about
50 A ˚ in diameter, consistent with the molecular structure of MBP.
Individual molecular images were aligned, classified, and averaged. A
number of the resulting class averages showed 2-fold rotational
symmetry, allowing the generation of averaged images in which the
t e r m i n a lM B Pf u s i o na n dt h em y o m e s i nM y 9 – M y 1 3f i l a m e n tc o u l d
be unambiguously identified (Figure 5A). In these averages, the
dimeric myomesin My9–My13 filament has a length that is similar to
that derived from the X-ray composite model. Moreover, we could
not detect any side-to-side oligomerization. This finding is further
supported bycomplementarybiophysicaldata for My9–My13, which
do not indicate any further oligomerization (Figure S5).
The central region of the averaged EM image (Figure 5A)
associated with the myomesin filament is in excellent agreement
with the crystallographic My9–My13 model. The comparison
suggests that the five areas of highest protein density are associated
with the central C-terminal (My13)2 dimerization module and two
flanking Ig doublets, My11–My12 and My9–My10, on both sides
of the filament. In the crystal structures used to generate the
crystallographic My9–My13 filament model, these two doublets
are connected by shorter helices than the other myomesin/Ig
domain doublets (Figure 1), which leads to an appearance of Ig
domain tandems when the respective low-resolution-filtered
projections are displayed (Figure 5B).
C-Terminal Myomesin Architecture and Estimation of
Molecular Flexibility by Solution X-Ray Scattering
To further characterize the overall structure of the complete
My9–My13 myomesin filament in solution, we used small angle
X-ray scattering (SAXS) (Figure S6). The overall parameters
Figure 1. Overall filament architecture of the dimeric myomesin IgH domain array My9–My10–My11–My12–(My13)2–My129–My119–
My109–My99. (A) Schematic representation of the complete myomesin dimer. Those My domains that have been structurally investigated are shown
in violet (first molecule) and blue (second molecule). (B) Ribbon representation of the complete myomesin tail-to-tail filament structure, in two
different orientations, rotated around a horizontal axis by 90u. The helical linkers are shown in green. A ruler, providing an overall length estimate of
the filament, is shown below. The conserved My domain/helix interface areas, shown in Figure 2B, are boxed.
doi:10.1371/journal.pbio.1001261.g001
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My9–My13, in terms of simple bodies, is best represented by a
long cylinder 370 A ˚ in length (Table 2). The resulting low-
resolution shape of wild-type My9–My13 reconstructed ab initio
reveals an extended coiled conformation, in agreement with both
the EM and crystallographic models (Figure 5).
The computed distance distribution p(r) displays a series of
maxima at distances of 60 A ˚, 118 A ˚, and 165 A ˚ (Figure 4C),
which is characteristic of elongated particles with periodic domain
arrangements [17]. A comparison with the domain/domain
arrangement analysis of the composite My9–My13 structure
(Figure 4B) indicates that the additional peaks in the experimental
p(r) most likely arise from first, third, and fourth Ig domain
neighbors. We further computed a p(r) function for this composite
My9–My13 crystallographic model, and indeed all maxima
positions agree well with the experimental SAXS data
(Figure 4C). However, we observed reduced peak sharpness in
the experimental SAXS distance distribution p(r) compared with
the function computed from the crystallographic model
(Figure 4C). This suggests a limited flexibility in the Ig domain/
domain arrangements in the dimeric My9–My13 filament, in
agreement with our comparison of those Ig domain tandems for
which multiple crystal structures are available (Figure 3). To take
this properly into account, we applied the Ensemble Optimization
Method (EOM) [18] to generate an optimized ensemble that
yielded an improved fit, and the resulting p(r) function dis-
played peak heights proportional to the experimental p(r) (Table 2;
Figure S6B).
When using My9–My13 variants in which single proline
residues were introduced in two helical linkers, My11–My12
(K1457P) and My12–My13 (Y1551P), to disrupt their helical
conformation (Figure 2), most of the peaks in the p(r) function were
lost (Figure 4C). This was accompanied by a substantial decrease
in the maximum particle size (Table 2). The data from the
myomesin mutants thus show that the structural integrity of these
helical linkers is essential to establish the observed defined and
rigid myomesin filament architecture.
Quantification of Myomesin Molecular Elasticity by
Atomic Force Microscopy
The repeated structural pattern of at least four IgH modules in
the C-terminal part of myomesin strongly suggests an elastic role
for this segment. To test this hypothesis, we designed atomic force
microscopy (AFM) experiments using an approach that was
established to measure the level of molecular elasticity in the C-
terminal myomesin tandem My12–My13 [19]. We created a
modified version of the myomesin My9–My13 filament dimer by
fusing polyhistidine tags to each of the two distal N-terminal My9
Table 1. X-ray data collection, phasing, and refinement statistics.
Myomesin Construct My10–My11 (Native) My10–My11 (SeMet) My9–My11 (Native) My11–My13 (Native)
Data collection
Space group P212121 P212121 P21 P42
Unit cell dimensions a=38.2 A ˚ a=39.0 A ˚ a=61.5 A ˚ a=155.2 A ˚
b=74.7A ˚ b=73.8 A ˚ b=41.5 A ˚ c=106.3A ˚
c=89.4 A ˚ c=86.6 A ˚ c=84.9 A ˚
b=88.4
o
Wavelength (A ˚) 0.91508 0.97890 0.97699 1.0044
Resolution (A ˚) 23.5–1.85 (1.89–1.85) 20–2.62 (2.66–2.62) 30–2.49 (2.53–2.49) 20.0–3.50 (3.58–3.50)
Rmerge (%) 4.7 (49.7) 9.9 (38.9) 11.2 (51.6) 7.6 (29.3)
I/sI 33.9 (2.7) 22.6 (5.1) 11.1 (1.8) 10.8 (2.4)
Completeness (%) 99.9 (100) 99.3 (90.2) 99.0 (89.6) 93.8 (82.0)
Redundancy 6.9 (6.6) 2.4 (1.2) 3.3 (2.9) 2.7 (2.0)
Refinement
Resolution (A ˚) 23.5–1.85 (1.89–1.85) 25.0–2.50 (2.56–2.50) 20.0–3.50 (3.58–3.50)
Number of reflections/used for Rfree calculation 22,541/716 14,571/465 29,917/1,234
Rwork/Rfree (%) 18.9/23.9 20.9/27.1 21.7/26.6
Number of atoms
Protein 1,677 2,452 9,542
Ligands 19 16 —
Solvent 164 186 —
B-factors (A ˚2)
Protein 40.8 50.6 128.2
Ligands 43.2 65.1 —
Solvent 45.8 51.4 —
Root mean square deviations
Bond lengths (A ˚) 0.006 0.016 0.014
Bond angles (u) 0.995 1.577 1.567
Values in parentheses are for the highest resolution shell.
doi:10.1371/journal.pbio.1001261.t001
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probed the elasticity of the myomesin filament by adsorbing the
protein chain to an AFM tip and recording the applied force
versus the molecular extension. In the two sample traces shown
(Figure 6A), a consistent saw-tooth pattern with a regular spacing
can be observed, reflecting the sequential unfolding of individual
Ig domains in the myomesin filament. The increase in contour
length (DL) on unfolding can be measured with nanometer
precision as 29.7 nm (Figure 6B, left) [20], which is in good
agreement with the values expected for the unfolding of individual
Ig domains.
At low extension and low force, however, a plateau in the force–
extension curves can be observed (Figure 6A, arrows). No such
plateau has been observed for Ig domain arrays in other systems
investigated to date, suggesting a novel mechanism of unfolding.
At high pulling velocities (typically 1 mms
21), further substruc-
tures within these plateaus could not be resolved. Therefore, we
performed experiments with decreased pulling velocities
(10 nm s
21) in the critical extension range up to 50 nm, followed
by an accelerated pulling velocity of 100 nm s
21 above an
extension of 50 nm to reduce the overall experimental time. A
sample trace shows that the unfolding of four Ig domains can be
observed (Figure 6C, lower panel). Owing to the very low pulling
velocity, the unfolding force of the first myomesin Ig domain is low
and almost coincides with the plateau force. The plateau
preceding this first unfolding event contains substructures, which
can be seen when this region is enlarged (Figure 6C, central panel),
and four distinct peaks can be resolved. A contour length
histogram (Figure 6C, upper panel) reveals an average peak-to-
peak distance of 6 nm. These values are in good agreement with
the expected contour length increase upon unfolding of individual
a-helical segments between the Ig domains. Rapid transitions can
be observed between the peaks, indicating that a-helix unfolding is
a rapid process close to equilibrium. This is further supported by
repeated stretch (red) and relax (blue) curves within an individual
plateau (Figure 6D). Both stretching and relaxing cycles exhibit the
characteristic plateau. As soon as the molecule is relaxed, the
helices contract back and thus act as truly elastic springs at forces
around 30 pN. In summary, our AFM experiments suggest that
important molecular elasticity components of myomesin originate
from the helical connecting linkers between the Ig domains.
As the axial translational components for polypeptides in an a-
helical conformation (1.5 A ˚ per residue) and extended conformation
(3.6 A ˚ per residue) are known, the increase in length of a 20-residue
Figure 2. Conserved, repetitive IgH modules of My9, My10, My11, and My12. (A) Structure-based sequence alignment of My9, M10, My11,
My12 IgH modules and My13. The residue numbers of each of the five sequences are indicated on top. The approximate locations of secondary
structural elements are shown at the bottom (for further details see Figure S2). Highly conserved residues (:) and identical residues (*) are indicated in
the consensus sequence line. Those residues that are involved in My domain/helix interfaces are highlighted in complementary colors (dark colors for
specific hydrogen bonds, light colors for remaining interactions). The two residues (K1457 and Y1551) that have been mutated for SAXS studies (cf.
Figure 3C) are boxed. (B) Structurally conserved My domain/helix interface areas in My9, My10, My11, and My12. Interacting helix residues are labeled;
residues are boxed if involved in specific hydrogen bonds.
doi:10.1371/journal.pbio.1001261.g002
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intervals of up to 60 A ˚ when applying low pulling velocities in AFM
experiments therefore match our calculations, when the straighten-
ing of substantially tilted helix orientations, as observed in the
composite My9–My13 X-ray model (Figures 1 and 4), is also taken
into account. Extending these calculations to the complete dimeric
C-terminal myomesin filament, its estimated length with unfolded
helical linkers is about 860 A ˚, which is almost 2.5-fold its original
length, with an estimated increase in length of about 500 A ˚ under
low external forces (Movie S1).
Discussion
The M-band is believed to be the key strain sensor in muscle
sarcomeres, and important signaling events at or near the M-band
may be regulated by mechanical forces originating from this
region [1,2,21]. Members of the myomesin protein family have
been identified as key bridging molecules that connect the major
sarcomeric filaments in this central sarcomere segment [2].
Previous immuno-EM studies indicate that the overall orientation
of myomesin has both longitudinal and transversal components,
the latter being associated with the so-called M-bridges [10,11,22].
Although the precise orientation of different filament parts of
myomesin in the sarcomere is unknown, available experimental
data lead to a model in which the dimeric link via the C-terminal
My13 domain in myomesin filaments is across the central M-line
[13]. These data also assign myomesin an additional role in
compensating the observed unbalanced filament movements with
respect to the central M-line, which consequently requires a large
potential of molecular elasticity.
To quantify the amount of molecular elasticity in myomesin, we
applied AFM, an approach that has already been extensively used
to estimate the elastic properties of the giant filament protein titin
[23]. Titin filaments, however, assemble in parallel oligomeric
bundles, propagating both from the Z-disk and from the M-band,
and observed changes in persistence length have been estimated to
be proportional to the square of the number of filaments [7,24].
Therefore, single molecule stretching data may deviate from titin
elasticity mechanisms in vivo. Accordingly, Ig domain unfolding/
refolding, a process that is probably not generally reversible, has
been dismissed as a mechanism for molecular elasticity under
physiological conditions [23,25,26]. However, as there is no
evidence for parallel filament bundling in myomesin (Figure S5),
single molecule studies are suitable for estimating its level of
molecular elasticity. In reference to the conclusions on titin, our
model does not require additional unfolding of Ig domains, and, to
the best of our knowledge, such reversible molecular elasticity is
without precedent in any other filament system.
Figure 3. Limited flexibility of My–My domain arrangements, estimated from multiple crystal structures of identical My(n)–My(n+1)
domain tandems. The number of available structures, the length of connecting helices (number of residues), and the estimated tilt and twist angles
[40], defining the arrangement of adjacent My domains, are listed. The standard deviations of these angles provide an estimate of the level of My–My
domain flexibility observed. Each superposition uses the C-terminal My domain as the basis for superposition. The template structure is color-coded
as in Figure 1, and the remaining superimposed structures are grey. The N- and C-termini are labeled.
doi:10.1371/journal.pbio.1001261.g003
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extend by at about 500 A ˚ under low external forces (Movie S1),
provide a molecular model as to how myomesin could act as a
highly elastic molecular strain sensor. The data presented here
demonstrate that the established mechanism of molecular
elasticity—reversible unfolding/refolding of highly exposed a-
helical inter-domain inkers—is applicable for the complete
repetitive array of IgH modules along the C-terminal part of the
myomesin filament. These new findings are in agreement with
previous proof-of-principle data, in which we established suitable
structural biology and AFM protocols to investigate the C-terminal
My12–My13 tandem [16,19]. As the remaining domain structure
of the N-terminal part of myomesin is markedly different, it is
plausible that this mechanism of molecular elasticity is confined to
the C-terminal My9–My13 segment of myomesin.
The length of the C-terminal myomesin filament of approxi-
mately 36 nm (360 A ˚) accounts for 85% of the previously
estimated distance of about 44 nm between the pronounced M4
and M49 lines in the sarcomeric M-band, which are thought to
primarily consist of myomesin [2,11,22]. However, without more
precise knowledge of the composition of these bands it remains
uncertain whether bridging of the remaining distance requires
some level of myomesin stretching, which would be well within our
estimates of the range of myomesin extendability, or whether the
part of myomesin associated with M4/M49 is beyond the C-
terminal myomesin filament My9–My13 that we have investigat-
ed. Our AFM measurements of myomesin elasticity also match the
level of distance variability in the A-band observed in previous X-
ray diffraction studies [3,5].
Moreover, it will be of great interest to provide insight into how
the predicted elastic properties of the C-terminal myomesin
filament could functionally influence the nearby regions in
myomesin that are involved in the assembly of interacting protein
ligands, such as obscurin [15] and creatine kinase [27]. It remains
speculative at this stage whether the coupling of mechanical forces,
as they exist within the M-band, with molecular elasticity, as
shown for the C-terminal part of myomesin, or with the potential
regulation of kinase activity, as recently advocated for titin kinase
at the M-band/A-band transition zone [21], has functional
implications for interacting myomesin protein partners. Indeed,
the possibility of cross-talk between mechanical stress sensing and
signaling in muscle sarcomeres is an important question to be
addressed. Mapping our findings on physiological stretching
processes in the sarcomeric M-band is a challenging task for the
future that will ultimately require phenotypic animal model studies
with genetically modified versions of myomesin. Finally, it remains
to be seen whether reversible filament elasticity by repetitive
domain-connecting helix unfolding is unique to this M-bridge
protein, or whether it also occurs in other filament systems.
Materials and Methods
Protein Expression and Purification
The DNA sequences (MYOM1_HUMAN) encoding myomesin
domains My9–My13 (residues 1141–1666), My9–My11 (residues
1141–1447), My10–My11 (residues 1247–1447), and My11–My13
(residues 1352–1666) were amplified by PCR from existing
constructs [13]. The PCR products were cloned into the
pET151/D-TOPO vector (Invitrogen). The two My9–My13
single residue mutants (K1457P and Y1551P) were prepared by
standard mutagenesis protocols. The MBP–My9–My13 construct
was prepared by recloning the My9–My13 construct into a
pETM41 vector (European Molecular Biology Laboratory). All
vectors used in this study carry an N-terminal hexa-histidine tag
and a tobacco etch virus cleavage site N-terminal to the myomesin
encoding sequence. The constructs were expressed in Escherichia
coli strain BL21 (DE3) CodonPlus-RP. The purification protocol
included two steps: Ni-NTA affinity chromatography, followed by
size exclusion chromatography (GE, Superdex 200 16/60). When
required, the hexa-histidine tag was removed by 6–8 h of
incubation with tobacco etch virus protease. All purified proteins
were dialyzed into 25 mM Tris/HCl (pH 7.5), 150 mM NaCl,
and 5 mM b-mercaptoethanol.
X-Ray Crystallography
Crystals of myomesin protein fragments were grown by vapor
diffusion, by mixing equal volumes of protein solution (8 mg ml
21
for My10–My11; 8 mg ml
21 for My9–My11; 10 mg ml
21 for
My11–My13) and precipitant solution (0.2 M sodium nitrate, 18%
[w/v] polyethylene glycol 3350, and 5% [w/w] ethylene glycol for
My10–My11; 0.18 M magnesium acetate and 20% [w/v]
polyethylene glycol 3350 for My9–My11; 0.1 M 2-(N-morpholi-
no)ethanesulfonic acid [pH 6], 0.22 M lithium sulfate, and 13%
[w/v] polyethylene glycol 8000 for My11–My13). X-ray data were
collected on the tunable wiggler beamline BW6 (My10–My11
seleno-L-methionine [SeMet], MPG/DESY, Hamburg, Ger-
many), on X12 (My9–My11 EMBL/DESY, Hamburg, Germany),
and on BM14 (My10–My11 native, European Synchrotron
Radiation Facility, Grenoble, France), and ID23-1 (My11–
My13, European Synchrotron Radiation Facility). All datasets
were collected at 100 K using 2-methyl-2,4-pentanediol as cryo-
protectant and were integrated, scaled, and merged using the
HKL suite [28]. The My10–My11 structure was determined by
using phases calculated from the anomalous signal of SeMet-
incorporated protein. The My9–My11 structure was solved by
molecular replacement using the individual Ig domains from
My10–My11 as models in MOLREP [29]. The My11–My13
structure was solved by molecular replacement using the (My13)2
dimer module from the My12–My13 structure (2R15) and
manually fitting the remaining My11 and My12 domains. The
My9–My11 structure was refined by maximum likelihood
including TLS refinement, as implemented in REFMAC5 [30].
Only two residues (0.7%) are found in generously allowed regions
of the Remachandran plot. The native My10–My11 and My11–
My13 structures were refined using the PHENIX suite [31],
implementing maximum likelihood, simulated annealing, and TLS
refinement protocols and, in addition, non-crystallographic
symmetry restraints for My11–My13. For the My10–My11
structure all residues are found in the most favored or additionally
allowed regions of the Ramachandran plot, whereas for My11–
My13, 33 residues (3.0%) are located in generously allowed
regions. Details of X-ray data collection and refinement are listed
in Table 1. The composite dimeric My9–My13 structure was built
by superimposing the My11 domain of the My11–My13 structure
(chain A) and the My11 from the My9–My11 structure. Based on
the observed limited tilt/twist angle variation (Figure 3C),
additional composite My9–My13 models were generated. These
models led to the same conclusions when compared with the EM
and SAXS data.
Electron Microscopy
Pure MBP–My9–My13 was diluted to 10 mgm l
21 and applied
for 1 min onto a glow-discharged carbon-coated grid and
subsequently stained with 2% uranyl acetate. Micrographs were
recorded using a Tecnai G2 Spirit electron microscope (FEI
electron optics) at a calibrated magnification of 41,4006 and an
accelerating voltage of 120 kV onto SO163 Kodak films. The
micrographs were digitized in a SuperCoolscan 9000 Nikon
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PLoS Biology | www.plosbiology.org 7 February 2012 | Volume 10 | Issue 2 | e1001261Figure 4. Analysis of the repetitive structural features of the My9–My13 tail-to-tail filament. (A) Surface presentation of the complete
My9–My13 filament, with the centers of gravity indicated by spheres for each My domain. (B) Center of gravity distances, calculated for all My domain
neighbor categories, from first (n, n+1) to eighth (n, n+8). (C) SAXS distance distribution plot of the wild-type My9–My13 filament (red) and two
mutants K1457P (violet) and Y1551P (blue). The SAXS distance distribution plot calculated for the composite My9–My13 X-ray model is shown for
comparison (thin red line). Matching additional maxima at about 60 A ˚, 115 A ˚, and 165 A ˚ distances are indicated by dashed vertical lines.
doi:10.1371/journal.pbio.1001261.g004
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binned by a factor of three, resulting in a sampling of 4.6 A ˚/pixel
at the specimen level. 2,075 particles were selected manually using
the program BOXER in EMAN [32]. Particles were Fourier
filtered using a high pass of 100 A ˚ and a low pass of 15 A ˚. They
were initially aligned to a reference corresponding to a streak of
density with width and length similar to that of the particles. The
dataset was submitted to multivariate statistical analysis using the
image processing software IMAGIC [33] followed by classification
and averaging. A selection of class averages acted in turn as
references for alignment of the particles using the image processing
software SPIDER [34]. Successive iterations of alignment,
multivariate statistical analysis, classification, and averaging were
carried out, and a final selection was made from a set of 100 class
averages. The coordinates from the X-ray composite model were
converted into density map representations using IMAGIC [33].
This map was filtered to 30 A ˚ resolution, and a model projection
image for comparison with the electron microscope data was
generated by projection of the map over the full range of possible
orientations.
Small Angle X-Ray Scattering
Scattering data from purified myomesin fragments My9–My13,
My9–My13(K1457P), and My9–My13(Y1551P) were measured at a
concentration range of 4–15 mg ml
21, each with intermittent buffer
solution (25 mM Tris/HCl [pH 7.5] and 150 mM NaCl), at beamline
X33 (EMBL/DESY, Hamburg, Germany). The measurements were
carried out at 290 K, using a sample–detector distance of 2.7 m,
covering the momentum transfer range 0.10 nm
21,s,4.5 nm
21
(s=4p sin(h)/l,w h e r e2 h is the scattering angle). The data were
processed using standard procedures, corrected for buffer contribution,
and extrapolated to infinite dilution using the program PRIMUS [35].
The radius of gyration Rg and forward scattering I(0), the maximum
particle dimension Dmax, and the distance distribution function p(r)
were evaluated using the program GNOM [36].The molecular masses
of the different constructs were calculated by comparison with
reference bovine serum albumin samples. The scattering patterns
from the high-resolution models were calculated by the program
CRYSOL [37]. Seventeen ab initio models were reconstructed from
the My9–My13wild-type scattering data using the simulated annealing
program DAMMIN [38]. The SAXS data statistics are summarized in
Figure 5. Cross-validation of the overall structure of the dimeric tail-to-tail My9–My13 filament. (A) Two-fold symmetry class average
with superimposed iso-density contours. Seven stained domains can be recognized, with the two distal ones corresponding to the two terminal
tagged MBP domains. The five central domains have been interpreted to be associated with the My9–My10 tandems (peaks 1 and 5), the two My11–
My12 tandems (peaks 2 and 4), and the central My13 dimerization modules (peak 3). My9–My10 and My11–My12 are connected by shorter helices
and therefore are less resolved as separate entities than My10–My11 and My12–My13, which are connected by longer helices (cf. Figure 1). (B) 2-D
forward projection of the X-ray composite model of the dimeric My9–My13 filament (cf. Figure 1) low pass filtered to 30 A ˚ in an orientation matching
that of the EM class average. (C) Surface representation of an ab initio SAXS model of the My9–My13 filament. The My9–My13 dimer, as indicated on
the right, exhibits a consistent arrangement in all data derived from EM, X-ray, and SAXS.
doi:10.1371/journal.pbio.1001261.g005
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from the crystal structure within root mean square deviation up to
10 A ˚ using the low frequency normal modes [39]. EOM [18] was
employed to find the mixtures of the modified structures that best fit the
experimental data (Table 2), and a modified p(r)f u n c t i o nw a s
computed (Figure S6B).
Atomic Force Microscopy
Single molecule force spectroscopy of My9–My13 dimers was
performed on a custom-built atomic force microscope. Protein
solution was adsorbed to freshly activated Ni-NTA-coated glass
slides for 5–10 min and then rinsed with buffer (25 mM Tris/HCl
[pH 7.5] and 150 mM NaCl) before starting the experiment. For
all experiments, gold-coated cantilevers (Biolever type B, Olym-
pus) with typical spring constants of 6 pN nm
21 were used.
Cantilever deflection and piezo stage movement were recorded at
20 kHz. Data acquisition and analysis were performed using
custom software within Igor Pro (Wavemetrics). Expected contour
length increases were estimated from the difference between the
contour length contribution of the end-to-end distance of the
folded structure and the contour length of the corresponding
Table 2. Solution X-ray scattering data statistics.
Sample Wild-Type K1457P Y1551P Calculated
Molecular mass (kDa)
a 130615 115615 110615 129
Maximum size, Dmax (A ˚)
b 370620 320620 310620 361
Radius of gyration Rg (A ˚)
b 98658 4 657 9 659 9
Particle excluded
volume (10
3 A ˚3)
c
220620 200620 190620
x, composite My9–My13
X-ray model
d
3.0 4.0 4.2
aMolecular mass from comparison with reference solutions of bovine serum
albumin; calculated mass from My9–My13 sequence, assuming a dimer.
bValues have been obtained by indirect transformation of the scattering data
using GNOM; the calculated values are from the composite My9–My13 X-ray
model.
cAveraged values of multiple ab initio DAMMIN models that provide the fit with
x=1.1.
dDiscrepancy values (x) have been calculated by CRYSOL. The ensemble of
normal-mode-analysis-based models optimized by EOM provides the fit with
x=1.2.
doi:10.1371/journal.pbio.1001261.t002
Figure 6. Atomic force microscopy measurements. (A) Typical force–extension traces of My9–My13 unfolding. Domain unfolding events are
marked by circles. Fits to the worm-like chain model (black traces) provide contour length increases, DL, from single domains unfolding. Regions of
plateau force areindicated by arrows. (B)Histograms of measured contour length increases (left,black trace is Gaussian fit) anddomainunfolding forces
(right). (C) Single force–extension measurement of My9–My13 (bottom) with slow pulling between 0 and 50 nm extensions. The zoom into the plateau
region exhibits a substructure; black traces are worm-like chain fits. The conversion of the plateau data points to contour lengths leads to the histogram
shown on top, which is fitted by Gaussians (black traces). (D) Sample traces at the plateau region when stretch (red) and relaxation (blue) cycles were
introduced into the otherwise continuous stretching of My9–My13. Both stretch and relaxation cycles feature the force plateau and show no hysteresis.
doi:10.1371/journal.pbio.1001261.g006
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multiplied by the average length contribution per amino acid,
which has been determined to be 0.36560.002 nm for our
instrument using various proteins for calibration and a fixed
persistence length of 0.5 nm [20].
Accession Codes
The coordinates and experimental structure factors of the X-ray
structures determined are deposited in the RCSB Protein Data
Bank (http://www.rcsb.org; 2Y23, 2Y25, and 3RBS).
Supporting Information
Figure S1 Myomesin crystal structures used for the
composite My9–My13 model. Color codes are as in Figure 1.
The resolution limit of each structure and Protein Data Bank
identifier are listed. Those structures that include the C-terminal
My13 domain form dimeric filament structures.
(PDF)
Figure S2 Structural features of single Ig domains My9,
My10, My11, My12, and My13. Upper panel, topology
diagrams. Secondary structural elements are labeled, and the
residue numbers of their boundaries are indicated. Lower panel,
ribbon diagrams of the same My domains. The color codes are
defined in Figure 1. Secondary structural elements in special
locations are highlighted in red. For details see text.
(PDF)
Figure S3 Analysis of My domain arrangements. (A)
Superposition of helix/Ig domain segments, indicating variable
arrangements.(B) SuperpositionofIgdomain/helix(IgH)segments,
indicating structurally identical arrangements (Figure 2B). (C) Tilt/
twist angle plot of helix/Ig domain segments from available X-ray
structures (cf. Figure 3). For color definitions, see (A).
(PDF)
Figure S4 Experimental electron microscopy data. (A)
Typical field from an electron micrograph of negatively stained
MBP–My9–My13 with representative particles boxed in white. (B)
Selection of aligned single particles of MBP–My9–My13. (C)
Selection of four representative class averages of MBP–My9–
My13. Scale bars: 20 nm.
(PDF)
Figure S5 Biophysical characterization of the My9–
My13 filament. (A) SDS-PAGE and (B) native electrophoresis
gel results. The molecular weights of some markers near the
observed bands are indicated. (C) Size exclusion chromatography
on an analytical Superdex 200 10/300 GL column; calibration
standards are indicated. The estimate of the molecular weight by
static light scattering was 14363 kDa, associated with a
polydispersity value MW/Mn=1.002 (4%). M, markers; P,
My9–My13.
(PDF)
Figure S6 SAXS data interpretation. (A) Experimental
SAXS data: wild-type My9–My13, red; My9–My13(Y1551P),
violet; My9–My13(K1457P), blue. (B) Comparison of the distance
distribution functions of the wild-type My9–My13. The curves
computed from the experimental SAXS data (red) and the
crystallographic model (thin red line) have been taken from
Figure 4C. In addition, the curve computed from the EOM-
modified model is shown (thin black line).
(PDF)
Text S1 Analysis of the myomesin Ig domain topology.
(DOC)
Movie S1 Molecular elasticity in the dimeric tail-to-tail
myomesin My9–My13 filament. T h ef i r s tp a r to ft h em o v i e
illustrates the overall architecture by zooming into and rotating the
My9–My13 filament composite model and labeling the individual
My domains (cf. Figure 1). The second part illustrates the collective
effect that was observed in the AFM experiments (cf. Figure 6),
mapped on the complete dimeric My9–My13 filament, allowing it to
stretch by about 2.5 times its original length. The length estimates are
indicated with a ruler. The extended model was builtby straightening
all Ig domains to one common orientation and by assuming unfolded
helical linkers, as defined in Figures 2 and 3, with Ca–Ca spacings of
3.8 A ˚. The estimated length for all straightened My domain modules
is 290 A ˚, and for unfolded helical linkers 570 A ˚, leading to an overall
length of 860 A ˚, which is 2.5 times the length of the X-ray-based
composite My9–M13 model, in the absence of external forces
(340 A ˚). The color codes are as in Figure 1.
(MPEG)
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